GO:0046328 regulation of JNK cascade: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046328 (regulation of JNK cascade) is a biological process that modulates the frequency, rate or extent of signal transduction mediated by the JNK cascade.
• The JNK cascade is a stress-activated MAPK pathway that controls apoptosis, proliferation, differentiation and inflammatory gene expression.
• Regulation occurs at multiple levels, including upstream MAP3K/MAP2K modules, scaffold proteins, phosphatases and post-translational modifications.
• Dysregulated JNK signaling contributes to psoriasis, cerebral ischemia/reperfusion injury, bone resorption and cancer.
• Key regulators include Ror2, Sfrp4, RIPK3/AIF, Jun/Fos AP-1 factors and mitochondrial SAB.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of JNK cascade regulators in disease.
Description
The JNK cascade is a mitogen-activated protein kinase (MAPK) signaling module that converts environmental and intracellular stress into transcriptional and apoptotic responses. GO:0046328, regulation of JNK cascade, describes any process that modulates the frequency, rate or extent of signal transduction mediated by this cascade. Because JNK activity is tightly controlled, even modest changes in its regulation can shift cell fate decisions between survival, proliferation and death. Researchers study this term to understand how upstream receptors, scaffold proteins, kinases and phosphatases set the threshold for JNK activation in normal physiology and disease. Dysregulated regulation of the JNK cascade is implicated in psoriatic keratinocyte hyperproliferation, cerebral ischemia/reperfusion injury, excessive osteoclast-mediated bone resorption and neoplastic transformation. Consequently, tools that can precisely perturb JNK cascade regulators, such as CRISPR knockout and knock-in models, are central to mechanistic and translational studies.
regulation of JNK cascade At A Glance
| GO ID | GO:0046328 |
|---|---|
| GO term | regulation of JNK cascade |
| Ontology | biological_process |
| Synonym | regulation of SAPK cascade |
| Definition | Any process that modulates the frequency, rate or extent of signal transduction mediated by the JNK cascade. |
| Major function | Modulates stress-activated MAPK signaling that controls apoptosis, proliferation, differentiation and inflammatory gene expression. |
| Key upstream regulators | Ror2, Sfrp4, RIPK3/AIF, mitochondrial SAB and AP-1 transcription factors. |
| Associated diseases | Psoriasis, cerebral ischemia/reperfusion injury, pathological bone resorption and cancer. |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, RNA-seq, proteomics, imaging and biochemical kinase assays. |
What Is GO:0046328?
In our own words, GO:0046328 (regulation of JNK cascade) encompasses any molecular or cellular process that adjusts the strength, duration or timing of signal transduction through the JNK MAPK cascade. It does not describe the core cascade reactions themselves, but rather the modulatory inputs, feedback loops and checkpoints that determine whether and how strongly JNK signaling proceeds.
Why Is regulation of JNK cascade Important in Cell Biology?
Regulation of the JNK cascade is important because it determines whether cells survive or die under stress, how immune and inflammatory genes are expressed, and how tissues respond to injury. Experimental evidence shows that JNK/c-Jun activation enhances malignant proliferation of psoriatic keratinocytes by regulating ROS levels and mitochondrial membrane potential, while RIPK3/AIF-dependent necroptosis contributes to global cerebral ischemia/reperfusion injury through JNK pathway regulation. In bone, Sfrp4 repression of the Ror2/Jnk cascade in osteoclasts protects cortical bone from excessive endosteal resorption. These examples illustrate that precise control of JNK cascade activity is essential for normal physiology and that its dysregulation drives diverse pathologies.
• Controls stress-induced apoptosis and cell survival decisions.
• Regulates inflammatory and AP-1-dependent gene expression.
• Modulates keratinocyte proliferation in psoriasis.
• Mediates necroptosis in cerebral ischemia/reperfusion injury.
• Restrains osteoclast-mediated endosteal bone resorption.
• Integrates mitochondrial signals such as SAB and ROS.
• Provides targets for cancer and inflammatory disease research.
• Enables CRISPR-based causal gene validation.
• Connects GqPCR signaling to apoptotic outputs.
• Serves as a model for MAPK pathway cross-talk with ERK.
What Happens During regulation of JNK cascade?
Upstream activation of MAP3K and MAP2K modules
In simple terms: First, signals from receptors or stress sensors turn on a relay of kinases that will eventually activate JNK.
Regulation of the JNK cascade begins with upstream inputs that activate MAP3K and MAP2K enzymes, which in turn phosphorylate and activate JNK. GqPCR signaling can trigger JNK cascade-induced apoptosis through this kinase relay. Post-translational modifications and scaffold proteins further shape the efficiency of these upstream activation events.
Scaffold and adaptor control of JNK module assembly
In simple terms: Scaffold proteins hold the kinase components together so the signal passes efficiently and specifically.
Scaffold and adaptor proteins organize the JNK module to ensure signal fidelity and to prevent inappropriate cross-talk with other MAPK pathways. Mitochondrial SAB is an example of a component that influences JNK signaling through its interplay with upstream post-translational effects. Such spatial organization is a key layer of regulation of the JNK cascade.
Phosphorylation and activation of JNK substrates
In simple terms: Once JNK is active, it tags transcription factors and other proteins with phosphate groups to change their behavior.
Activated JNK phosphorylates substrates including Jun and Fos AP-1 transcription factors, thereby reprogramming gene expression. In areca nut extract-treated KB cells, JNK MAPK signaling regulates Jun and Fos AP-1 transcription factors. This substrate phosphorylation step is a central output of regulation of the JNK cascade.
Mitochondrial and ROS feedback regulation
In simple terms: The pathway talks back to mitochondria, and mitochondrial signals talk back to the pathway.
JNK/c-Jun cascade activation enhances malignant proliferation of psoriatic keratinocytes by regulating ROS levels and mitochondrial membrane potential. Mitochondrial SAB and upstream post-translational effects also modulate JNK signaling in cell death. These feedback loops illustrate how regulation of the JNK cascade integrates mitochondrial physiology with stress signaling.
Termination by phosphatases and negative feedback
In simple terms: Finally, phosphatases and feedback loops switch the signal off so it does not run forever.
Negative regulation of the JNK cascade involves phosphatases and feedback mechanisms that dephosphorylate JNK and its upstream kinases. The balance between activating and terminating inputs determines the duration and magnitude of JNK signaling. Loss of such restraint can contribute to pathological outcomes such as excessive bone resorption or ischemia/reperfusion injury.
Key Genes Involved in GO:0046328 regulation of JNK cascade
The following genes and proteins are established participants or regulators of the JNK cascade and are commonly studied in this context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAPK8 (JNK1) | Core JNK kinase | Central effector of the cascade |
| MAPK9 (JNK2) | Core JNK kinase | Contributes to stress-induced signaling |
| MAPK10 (JNK3) | Neuronal JNK kinase | Implicated in cerebral ischemia/reperfusion injury |
| JUN | AP-1 transcription factor substrate | Mediates JNK-dependent gene expression |
| FOS | AP-1 transcription factor substrate | Regulated by JNK MAPK signaling |
| ROR2 | Upstream receptor tyrosine kinase-like regulator | Repressed by Sfrp4 in osteoclasts |
| SFRP4 | Secreted Wnt antagonist | Represses Ror2/Jnk cascade in osteoclasts |
| RIPK3 | Necroptosis regulator | Links JNK pathway to necroptosis in brain injury |
| AIF (AIFM1) | Mitochondrial death effector | Cooperates with RIPK3/JNK in necroptosis |
| SAB (SH3BP5) | Mitochondrial scaffold protein | Modulates JNK signaling in cell death |
| MAP3K family | Upstream kinases | Activate JNK module |
| MAP2K4/7 | JNK-specific MAP2K | Phosphorylate and activate JNK |
| DUSP family | JNK phosphatases | Terminate JNK signaling |
| CYP450 genes | Downstream metabolic effectors | JNK-ERK synergistic regulation in insecticide resistance |
| GqPCR | G protein-coupled receptor class | Triggers JNK cascade-induced apoptosis |
| ROS regulators | Redox modulators | Feedback to JNK/c-Jun in keratinocytes |
| Mitochondrial membrane potential regulators | Bioenergetic modulators | Linked to JNK/c-Jun-driven proliferation |
How Is regulation of JNK cascade Regulated?
Regulation of the JNK cascade is itself controlled by multiple layers, including upstream receptor signaling, scaffold proteins, post-translational modifications and phosphatases. Mitochondrial SAB and upstream post-translational effects modulate JNK signaling during cell death. JNK-ERK synergistic regulation of P450 gene expression demonstrates cross-talk between MAPK pathways in controlling downstream outputs. In psoriatic keratinocytes, JNK/c-Jun activation regulates ROS levels and mitochondrial membrane potential, creating a feedback loop that sustains proliferation. RIPK3/AIF signaling also intersects with JNK pathway regulation in necroptosis-mediated cerebral ischemia/reperfusion injury. These examples show that regulation of the JNK cascade is not a simple on/off switch but a dynamic network of positive and negative inputs.
regulation of JNK cascade and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| JUN | Psoriasis / keratinocyte hyperproliferation | Knockout or overexpression in keratinocyte lines |
| RIPK3 | Cerebral ischemia/reperfusion injury | Knockout rat or mouse models |
| AIFM1 | Necroptosis in brain injury | Knockout or point-mutation models |
| SFRP4 | Excessive endosteal bone resorption | Osteoclast-specific knockout or overexpression |
| ROR2 | Osteoclast-mediated bone resorption | Knockout or knock-in reporter models |
Psoriasis and inflammatory skin disease
JNK/c-Jun cascade activation enhances malignant proliferation of psoriatic keratinocytes by regulating ROS levels and mitochondrial membrane potential. This links regulation of the JNK cascade directly to keratinocyte hyperproliferation and inflammatory skin pathology.
Cerebral ischemia/reperfusion injury
Regulation of the JNK signaling pathway and RIPK3/AIF contributes to necroptosis-mediated global cerebral ischemia/reperfusion injury in rats. This positions JNK cascade regulation as a mechanistic node in neuronal death after ischemic stroke.
Bone resorption disorders
Sfrp4 repression of the Ror2/Jnk cascade in osteoclasts protects cortical bone from excessive endosteal resorption. Dysregulated JNK cascade activity in osteoclasts can therefore drive pathological bone loss.
Cancer and apoptosis control
JNK cascade-induced apoptosis plays a unique role in GqPCR signaling, and apoptosis regulators are frequently linked to JNK pathway activity. Because JNK can promote either survival or death depending on context, its regulation is a critical determinant of cancer cell fate.
From regulation of JNK cascade-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for JNK cascade activation? | CRISPR knockout cell line |
| Does a specific phosphorylation site control JNK output? | Point-mutation knock-in |
| How does a disease variant alter JNK signaling? | Knock-in of the variant allele |
| Where and when is a JNK regulator expressed? | Tagged knock-in reporter |
| Does overexpression of a regulator drive proliferation? | Overexpression cell model |
| Which genes modify JNK-dependent phenotypes? | CRISPR library screening |
How to Study the regulation of JNK cascade Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes | Profiling JUN/FOS target genes |
| Phosphoproteomics | Phosphorylation events | Mapping JNK substrate phosphorylation |
| Live-cell imaging | ROS and mitochondrial membrane potential | Studying JNK/c-Jun effects in keratinocytes |
| Immunoblotting | Phospho-JNK levels | Quantifying cascade activation |
| Kinase assay | JNK enzymatic activity | Testing upstream regulators |
| CRISPR screening | Gene essentiality for JNK phenotypes | Identifying novel regulators |
| Necroptosis assays | RIPK3/AIF-dependent cell death | Modeling cerebral ischemia/reperfusion injury |
RNA-seq and transcriptomics
RNA-seq can quantify changes in JNK cascade target genes such as JUN and FOS after perturbation of regulators. It is widely used to profile AP-1-dependent transcriptional outputs in cells treated with stressors like areca nut extract.
Proteomics and phosphoproteomics
Phosphoproteomics measures JNK substrate phosphorylation and upstream kinase activity, providing a direct readout of regulation of the JNK cascade. Post-translational modifications that modulate JNK signaling can be mapped by these approaches.
Imaging and mitochondrial assays
Live-cell imaging of ROS levels and mitochondrial membrane potential reveals how JNK/c-Jun activation affects keratinocyte proliferation. Mitochondrial SAB localization and dynamics can also be visualized to study JNK regulation.
Biochemical kinase assays
In vitro kinase assays and immunoblotting for phospho-JNK provide quantitative measures of cascade activation and its regulation. These assays are often combined with knockout or point-mutation models to establish causality.
How CRISPR Can Be Used to Study GO:0046328 regulation of JNK cascade
Knockout
CRISPR knockout of candidate regulators such as SFRP4 or ROR2 can test whether they are required for JNK cascade activity in osteoclasts and other cells. Knockout of JUN or FOS can reveal their contribution to JNK-dependent transcription.
Point Mutation
Point-mutation knock-in of phosphorylation sites in JNK substrates or upstream kinases can dissect which residues are critical for regulation of the JNK cascade. Such models help distinguish catalytic from scaffolding functions.
Knock-in
Knock-in of disease-associated variants or tagged alleles allows tracking of JNK regulators in their endogenous context. Reporter knock-ins can visualize pathway activity in real time.
Overexpression
Overexpression of JNK cascade components such as JUN or upstream activators can drive proliferation or apoptosis, modeling disease phenotypes like psoriasis. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports regulation of JNK cascade Research
Researchers studying regulation of JNK cascade-related genes often need to determine whether a candidate gene is causally involved in pathway activation, substrate phosphorylation or disease phenotypes. EDITGENE provides CRISPR-based cell models and screening services to enable these causal experiments.
Contact EDITGENE today to design your custom CRISPR model for regulation of JNK cascade research.
Frequently Asked Questions About regulation of JNK cascade
What is GO:0046328 regulation of JNK cascade?
GO:0046328 is a biological process term describing any process that modulates the frequency, rate or extent of signal transduction mediated by the JNK cascade.
What genes are involved in regulation of the JNK cascade?
Key genes include MAPK8, MAPK9, MAPK10, JUN, FOS, ROR2, SFRP4, RIPK3 and AIFM1.
How is the JNK cascade regulated?
It is regulated by upstream MAP3K/MAP2K modules, scaffold proteins, post-translational modifications and phosphatases.
What diseases are linked to JNK cascade dysregulation?
Psoriasis, cerebral ischemia/reperfusion injury, pathological bone resorption and cancer have been linked to JNK cascade dysregulation.
What is the synonym for GO:0046328?
The synonym is regulation of SAPK cascade.
How can CRISPR help study regulation of the JNK cascade?
CRISPR knockout, point mutation, knock-in and overexpression models can test causal roles of JNK cascade regulators.
Which transcription factors are JNK substrates?
Jun and Fos AP-1 transcription factors are regulated by JNK MAPK signaling.
Does JNK signaling interact with other MAPK pathways?
Yes, JNK-ERK synergistic regulation of P450 gene expression demonstrates cross-talk between MAPK pathways.
What role does RIPK3 play in JNK-related disease?
RIPK3 and AIF are involved in necroptosis-mediated cerebral ischemia/reperfusion injury through JNK pathway regulation.
What methods are used to study regulation of the JNK cascade?
Common methods include RNA-seq, phosphoproteomics, imaging, immunoblotting, kinase assays and CRISPR screening.
Conclusion
GO:0046328 regulation of JNK cascade is a central biological process that controls stress-activated MAPK signaling and determines cell fate, inflammatory gene expression and tissue responses to injury. Its dysregulation is implicated in psoriasis, cerebral ischemia/reperfusion injury, bone resorption disorders and cancer. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with transcriptomic and proteomic readouts, provide powerful tools to dissect these mechanisms.
References
- 1. Zhang Y et al.. 2025. JNK/c-Jun cascade activation enhances malignant proliferation of psoriatic keratinocytes by regulating ROS levels and mitochondrial membrane potential.. Eur J Med Res 30(1):754 PMID: 40826129
- 2. Hu W et al.. 2020. Regulation of JNK signaling pathway and RIPK3/AIF in necroptosis-mediated global cerebral ischemia/reperfusion injury in rats.. Exp Neurol 331:113374 PMID: 32502579
- 3. Chen K et al.. 2019. Sfrp4 repression of the Ror2/Jnk cascade in osteoclasts protects cortical bone from excessive endosteal resorption.. Proc Natl Acad Sci U S A 116(28):14138-14143 PMID: 31239337
- 4. Nadel G et al.. 2023. JNK Cascade-Induced Apoptosis-A Unique Role in GqPCR Signaling.. Int J Mol Sci 24(17) PMID: 37686335
- 5. Win S et al.. 2018. The Regulation of JNK Signaling Pathways in Cell Death through the Interplay with Mitochondrial SAB and Upstream Post-Translational Effects.. Int J Mol Sci 19(11) PMID: 30463289
- 6. Nagesh R et al.. 2021. Regulation of Jun and Fos AP-1 transcription factors by JNK MAPKs signaling cascade in areca nut extract treated KB cells.. Biochem Biophys Rep 27:101090 PMID: 34401529
- 7. Harada H et al.. 2003. Apoptosis regulators.. Rev Clin Exp Hematol 7(2):117-38 PMID: 14763159
- 8. Zhang G et al.. 2025. JNK-ERK Synergistic Regulation of P450 Gene Expression Confers Nitenpyram Resistance in Nilaparvata lugens (Stål).. J Agric Food Chem 73(13):7695-7703 PMID: 40123514
